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►Breast cancer is the leading new cancer diagnosis & 2nd highest 
cause of cancer death in American women (American Cancer 
Society, 2020) 
►Hereditary breast cancer is often caused by mutations in the 
BRCA 1 or 2 genes, with an associated 5 to 10-fold increase in 
breast cancer risk (Mayo Clinic, 2019)
►10% of individuals with a gene mutation are aware of this 
diagnosis (Drohan et al., 2012)
►The USPSTF issued a Grade B recommendation & advised use of 
a risk assessment tool for identifying women at high-risk, so 
appropriate referrals can be provided (Nelson et al., 2019)
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In women cared for in an obstetrical & gynecological practice (P) how 
does utilization of a breast cancer genetics referral screening tool (I) 
as compared to the current standard of care of collecting & reviewing 
family history in patients’ EMR (C) allow women at increased risk for 
hereditary breast cancer to be appropriately identified and referred for 
genetic counseling (O) within a twelve-week time frame (T)?
The Evidence Level and Quality guide from the Johns Hopkins Nursing Evidence-
Based Practice was used to appraise the evidence (Dang & Dearholt, 2017)
Search Terms: (1) “breast neoplasm” or “breast cancer” and 
(2) “family history” or genetic or hereditary or “high risk” or inherited or 
predisposition and (3) apprais* or “risk assessment” or tool* and 
(4) refer*
Inclusion Criteria: English, female, published 2012-2019, academic 
journal, scholarly/peer reviewed
Exclusion Criteria: Only women with history of breast cancer, breast 
cancer tumor gene testing, breast cancer risk perception, risk tool 
used during mammography for ordering MRIs, chemoprevention
Accepted: 10 pieces of evidence were appraised (829 yielded from 6 
databases, 100 reviewed, 10 duplicates)
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►Setting: Ob/Gyn practice with 5 offices in a Midwestern state
►Providers: 9 total, included 3 each of CNMs, NPs, and physicians
►Time Frame: 12 weeks
►Inclusion Criteria: > 18 y/o, routine gyne exam or new patient appt
►Exclusion Criteria: < 18 y/o, impaired mental capacity (dementia, 
mental retardation), appointment type other than those listed above, 
previously performed 
►Procedure: B-RST™ assessment performed by medical assistants 
(MAs) & reviewed by the provider with referrals ordered accordingly
►EBP Protocol: Management advised for B-RST™ results:
(1) NEGATIVE-AVERAGE RISK – monthly breast self 
examination & mammogram at appropriate age & interval
(2) NEGATIVE-MODERATE RISK – as above & referral 
to the High Risk Breast Clinic (HRBC)  
(3) POSITIVE-HIGH RISK – as above & referral to genetics
►Data Collection: Entering B-RST™ results in EMR, reviewing EMR 
populated reports, & performing EMR chart audits
►Pre-implementation Group: Demographics & total referrals to 
HRBC & genetics for patients meeting inclusion criteria as above 
(N = 880) for the same 12-week time period one year prior were 
obtained for comparison
►EBP Model: Iowa Model’s 7 steps guided this EBP project (2017)
►Breast Cancer Genetics Referral Screening Tool (B-RST™) received 
a high quality rating by USPSTF for assessing hereditary breast 
cancer risk (Nelson et al., 2019)
►B-RST™ Version 3.1 can be integrated in the EMR, has documented 
ease of use, & covers 1st & 2nd degree family history of breast & 
ovarian cancers, male breast cancer, & Ashkenazi Jewish heritage 
(Belcross et al., 2019)
►Offering medical management options to this at-risk group can 
promote breast cancer prevention or early detection to positively 
affect health outcomes (ACOG, 2019; Kiely & Schwartz, 2014)
Primary Outcomes:
1. Identify women at-risk
2. Refer women at-risk
►Eligible: N = 1253
►Screened: n = 994 
►Overall Protocol Adherence: 
79.3% - achieved goal of ≥ 75%
►HRBC Candidates: n = 249 
►Genetics Candidates: n = 174      
►HRBC Referrals 
Provided: n = 57, 22.9%
►Genetics Referrals 
Provided: n = 32, 8.4%    
►Use of the B-RST™ was an effective method at an Ob/Gyn office 
setting for identifying & providing referrals to women at-risk for 
hereditary breast cancer
►Continued B-RST™ use & improved participant referral performance 
necessary to support overall goal of medical management for 
promoting optimal health outcomes
►EBP Project Site: (1) Perform B-RST™ once yearly for all patients, 
(2) Improve referral provision rates & document if HRBC &/or 
genetics referrals were offered, accepted, &/or declined, & (3) 
Provide patient reported reasons for a referral being declined to aid in 
improving participation rates 
►Health Care Community: (1) Educate nursing/APRN/PA/medical 
students & health care providers about hereditary breast cancer risk 
& use of the B-RST™ & (2) Recognize & address barriers for 
providers ordering referrals & patients performing these consultations 
►Chi-Square Test for 
Independence: Pre- & post-
implementation group demographic 
variables were independent, 
indicating sampling representative 
of office population for age, appt 
type, insurance, race, & religion
► Factorial ANOVA: Significant 
effects with increases in referrals to 
HRBC & genetics with providers 
using the B-RST™ to guide 
decision-making 
Secondary Outcomes:
1. HRBC referral performance
2. Genetics referral performance
►HRBC Consultation 
Completed: n = 8 (14.0%)
►Genetic Consultation 
Completed: n = 7 (21.9%)
►HRBC Total Referrals Pre- to 
Post-Implementation: 51
►Genetics Total Referrals Pre-
to Post-Implementation:  24 
Group = Pre- or Post-Implementation  
Statistical significance at p < .05
Assessment Results
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